Drugs / Fecal microbiota transplantation
Trials 1
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 1/2 | NCT04758507 | Feb 2021 → Dec 2024 | renal cell carcinoma | Fondazione Policlinico Universitario Agostino Gemelli IRCCS | Completed | Missed primary |
Evidence & citations 5 cited values
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | Fecal microbiota transplantation | “Fecal microbiota transplantation (FMT) is a novel therapeutic option based on the restoration of healthy gut microbiota” NCT04758507 ↗ |
| Known as | FMT | ClinicalTrials.gov intervention name — accepted as the source's own label NCT04758507 ↗ |
| Action | Restore | “based on the restoration of healthy gut microbiota” NCT04758507 ↗ |
| Modality | Other / unclassified | “Fecal microbiota transplantation (FMT) is a novel therapeutic option based on the restoration of healthy gut microbiota” NCT04758507 ↗ |
| Route | Other | “Patients will undergo the first infusion by colonoscopy.” NCT04758507 ↗ |